Aqilion presents new results from the AQ312 program (oral Ahr agonist) during UEG Week in Vienna October 14, 2024
Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024 September 22, 2024
